Ocera Therapeutics (OCRX) Says Data Confirms OCR-002 Lowered Ammonia, Correlated Statistically with Clinical Improvement in Patients with HE Mar 8, 2017 08:13AM
Ocera to Announce Additional Encouraging Results from its Phase 2b STOP-HE Study of IV OCR-002 in Patients with Hepatic Encephalopathy Mar 8, 2017 08:05AM
Ocera to Present at the Cowen and Company 37th Annual Healthcare Conference Feb 28, 2017 04:05PM
Ocera to Present at the Cowen and Company 36th Annual Health Care Conference Feb 29, 2016 04:05PM
Trading Radar for 4/29: ExxonMobil (XOM), AIG (AIG), Visa (V), LinkedIn (LNKD), Mosaic (MOS) Report Apr 29, 2015 03:44PM


Feb 23, 2015 04:05PM Ocera Therapeutics to Present at 35th Annual Cowen and Company Health Care Conference
Jul 10, 2014 08:35AM Ocera Therapeutics (OCRX) Prices 4.2M Offering at $6/Share
Jul 10, 2014 08:33AM Ocera Therapeutics Raises $25.2 Million in Public Offering
Jul 9, 2014 04:03PM Ocera Therapeutics (OCRX) Announces Common Stock Offering
Jul 9, 2014 04:01PM Ocera Therapeutics Announces Proposed Public Offering of Common Stock
Feb 26, 2014 04:00PM Ocera Therapeutics to Present at the Cowen and Company 34th Annual Health Care Conference
Dec 17, 2013 08:13AM Cowen Starts Ocera Therapeutics (OCRX) at Outperform